USC Today

David Dadiomov

Expert in substance use disorders, addiction medicine, psychiatric disorders, pharmacy practice, psychopharmacology and harm reduction. Faculty advisor for USC’s student-led naloxone distribution program.
  • Clinical Assistant Professor, Clinical Coordinator
  • Clinical Pharmacy
  • USC Alfred E. Mann School of Pharmacy and Pharmaceutical Sciences
Links:

Expertise

  • Harm reduction initiatives such as low-barrier access to naloxone/Narcan, syringes, fentanyl test strips, xylazine test strips
  • Cannabis (therapeutic evidence, safety issues, addiction, cannabinoid profiles e.g. CBD, THC)
  • Treatments for alcohol use disorder; alcohol withdrawal issues
  • Fentanyl (fake/counterfeit pressed pills)
  • Heroin, Oxycontin/Percocet (oxycodone), Vicodin/Norco (hydrocodone), morphine, Dilaudid (hydromorphone)
  • Ketamine (therapeutic/illicit use, safety/efficacy)
  • Benzodiazepines (Xanax, Valium, Ativan, Klonopin, Librium)
  • Therapeutic/illicit use of psychedelic drugs (psilocybin mushrooms, MDMA, LSD, Peyote, Ayahuasca, DMT)
  • Methamphetamine, Amphetamine, Cocaine, Crack, Stimulants
  • Commonly-prescribed medications: •antidepressants (Zoloft, Prozac, Spravato, Lexapro, Celexa, Paxil, Effexor, Remeron) •antipsychotic medications (Haldol, Prolixin, Seroquel, Zyprexa, Risperdal, Abilify, Clozaril, Geodon, Thorazine) • ADHD medications (Adderall, Dexedrine, Ritalin) •Insomnia medications (Ambien, Lunesta, Sonata )

Languages

  • English
  • Russian